Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective
Grubb, Anders LU
; Christensson, Anders
LU
and Björk, Jonas
LU
(2021)
In American Journal of Kidney Diseases
77(5).
p.823-823
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/15516991-3299-4624-bf5b-2bb358a16c69
- author
- Grubb, Anders
LU
; Christensson, Anders
LU
and Björk, Jonas
LU
- organization
- publishing date
- 2021-05-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- American Journal of Kidney Diseases
- volume
- 77
- issue
- 5
- pages
- 1 pages
- publisher
- Elsevier
- external identifiers
-
- pmid:33571579
- scopus:85103305350
- ISSN
- 0272-6386
- DOI
- 10.1053/j.ajkd.2020.12.015
- language
- English
- LU publication?
- yes
- id
- 15516991-3299-4624-bf5b-2bb358a16c69
- date added to LUP
- 2021-04-08 10:53:12
- date last changed
- 2025-10-14 12:14:27
@article{15516991-3299-4624-bf5b-2bb358a16c69,
author = {{Grubb, Anders and Christensson, Anders and Björk, Jonas}},
issn = {{0272-6386}},
language = {{eng}},
month = {{05}},
number = {{5}},
pages = {{823--823}},
publisher = {{Elsevier}},
series = {{American Journal of Kidney Diseases}},
title = {{Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective}},
url = {{http://dx.doi.org/10.1053/j.ajkd.2020.12.015}},
doi = {{10.1053/j.ajkd.2020.12.015}},
volume = {{77}},
year = {{2021}},
}